Clinical Trial Update: Dapagliflozin on Volume Vascular Outcomes. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dapagliflozin on volume status and vascular outcomes in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Frank Ruschitzka | Conditions: Heart Failure，Congestive | Phase 4 | Status: COMPLETED